AGL 38.00 Increased By ▲ 0.50 (1.33%)
AIRLINK 222.50 Decreased By ▼ -0.39 (-0.17%)
BOP 10.84 Increased By ▲ 0.02 (0.18%)
CNERGY 7.57 Increased By ▲ 0.01 (0.13%)
DCL 9.42 No Change ▼ 0.00 (0%)
DFML 40.90 Decreased By ▼ -0.06 (-0.15%)
DGKC 105.00 Decreased By ▼ -1.76 (-1.65%)
FCCL 36.37 Decreased By ▼ -0.70 (-1.89%)
FFL 19.32 Increased By ▲ 0.08 (0.42%)
HASCOL 13.20 Increased By ▲ 0.02 (0.15%)
HUBC 131.61 Decreased By ▼ -1.03 (-0.78%)
HUMNL 14.55 Decreased By ▼ -0.18 (-1.22%)
KEL 5.32 Decreased By ▼ -0.08 (-1.48%)
KOSM 7.60 Increased By ▲ 0.12 (1.6%)
MLCF 47.41 Decreased By ▼ -0.77 (-1.6%)
NBP 66.47 Increased By ▲ 0.18 (0.27%)
OGDC 222.75 Decreased By ▼ -0.51 (-0.23%)
PAEL 44.65 Increased By ▲ 1.15 (2.64%)
PIBTL 9.10 Increased By ▲ 0.03 (0.33%)
PPL 197.00 Decreased By ▼ -1.24 (-0.63%)
PRL 42.10 Decreased By ▼ -0.14 (-0.33%)
PTC 27.20 Decreased By ▼ -0.19 (-0.69%)
SEARL 109.01 Decreased By ▼ -1.07 (-0.97%)
TELE 10.50 Decreased By ▼ -0.02 (-0.19%)
TOMCL 36.57 Decreased By ▼ -0.05 (-0.14%)
TPLP 14.90 Decreased By ▼ -0.05 (-0.33%)
TREET 26.65 Increased By ▲ 0.12 (0.45%)
TRG 68.35 Decreased By ▼ -0.50 (-0.73%)
UNITY 34.10 Decreased By ▼ -0.09 (-0.26%)
WTL 1.76 Decreased By ▼ -0.03 (-1.68%)
BR100 12,441 Increased By 77.6 (0.63%)
BR30 38,180 Decreased By -38.4 (-0.1%)
KSE100 117,469 Increased By 349.5 (0.3%)
KSE30 37,046 Increased By 108.5 (0.29%)

ISLAMABAD: There are currently more than 500 alternative medicine manufacturers of which almost 80 percent of the setups do not have testing laboratories.

And if any at all, they have been non-functional due to lack of technical stuff, according to a survey.

After the enactment of the DRAP Act, 2012, for the first time in the history of Pakistan nutraceuticals and alternative medicines were brought under the ambit of drug laws.

In this regard, Alternative Medicines and Health Products (Enlistment) Rules, 2014 was notified and the process of enlistment of nutraceuticals and alternative medicine was started.

According to Enlistment rules, the manufacturer is responsible for quality, safety, and efficacy of the product.

In accordance with this, the DRAP has issued a letter on 27th October 2020 in which instructions to manufacturers of Alternative Medicine regarding the submission of their testing procedure in Drug Testing Laboratories have been given to analyse the quality of Alternative Medicines.

Since the 18th amendment, quality control check has been declared to be the responsibility of the provincial governments.

And yet, none of the provincial governments have made any efforts on ensuring the quality of products.

Medicines prescribed under the name of health boosters of substandard quality to patients are a serious harm to their health.

It is a fact that these medicines containing vitamin, mineral and amino acids require special equipment such as atomic absorption spectrophotometers and the HPLCs and by showing their presence in the factory premises, the said factory was enlisted for manufacture. Now, if the factory is not performing tests on ready for use bulk and on final product, the quality and quantity of the ingredient is not determined.

Absence of ingredient in the final product can lead to false hope given to the patients that they are taking the right nutritional supplement, whereas, improper mixing and over addition or unnecessary addition of some contaminants may lead to the damage to the patient’s organs such as liver and kidney.

In either case, the violation of the enlistment criteria is breached and the firm is liable to be prosecuted under prescribed rules, an expert told Business Recorder.

As prescribed by the Drug Act, 1976, those units manufacturing Alternative Medicine/pharmaceutical products not having functional laboratories must have their registration cancelled.

Copyright Business Recorder, 2021

Comments

Comments are closed.